MMC (MMC) CMO John Jude Jones sells 2,362 shares in open market

Rhea-AI Filing Summary

Marsh & McLennan Companies Chief Marketing Officer John Jude Jones reported an open-market sale of common stock. On March 11, 2026, he sold 2,362 shares at an average price of $173.6101 per share. After the sale, he directly held 7,978 shares, with an additional 1,819.885 shares held indirectly through the MMC 401(k) Savings & Investment Plan.

Insider Trade Summary

Net Seller: 2,362 shares ($410,067)

Net Sell 2 txns

Insider Jones John Jude

Role Chief Marketing Officer

Sold 2,362 shs ($410K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,362	$173.6101	$410K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 7,978 shares (Direct); Common Stock — 1,819.885 shares (Indirect, MMC 401(k) Savings & Investment Plan)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jones John Jude

(Last) (First) (Middle)

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARSH & MCLENNAN COMPANIES, INC. [ MRSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/11/2026		S		2,362	D	$173.6101	7,978	D
Common Stock								1,819.885	I	MMC 401(k) Savings & Investment Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Tessa Patti, Attorney-in-fact	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MMC Chief Marketing Officer John Jude Jones report?

John Jude Jones reported an open-market sale of Marsh & McLennan common stock. He sold 2,362 shares on March 11, 2026 at an average price of $173.6101 per share, according to the Form 4 filing.

At what price did MMC executive John Jude Jones sell his shares?

He sold the shares at an average price of $173.6101 per share. This price reflects the weighted average for the 2,362 common shares sold in an open-market transaction on March 11, 2026, as disclosed in the Form 4.

How many MMC shares does John Jude Jones hold after the reported sale?

Following the sale, John Jude Jones directly holds 7,978 shares of Marsh & McLennan common stock. He also has an indirect position of 1,819.885 shares held through the MMC 401(k) Savings & Investment Plan, based on the Form 4 data.

Was the MMC insider transaction by John Jude Jones a buy or a sell?

The transaction was a sale of common stock. The Form 4 shows an open-market sale (code S) of 2,362 shares of Marsh & McLennan at an average price of $173.6101 per share on March 11, 2026.

Does the MMC Form 4 show any option exercises or derivative transactions by John Jude Jones?

No option exercises or derivative trades are reported for this event. The Form 4 lists only a non-derivative open-market sale of 2,362 common shares and an updated indirect holding balance in the MMC 401(k) Savings & Investment Plan.